These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2506695)

  • 21. Rosetting, phagocytosis and immune red cell damage.
    Zupańska B
    Clin Lab Haematol; 1990; 12(3):309-20. PubMed ID: 2125543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison between Fc receptors for IgG1 and IgG3 on human monocytes and lymphocytes using anti-Rh antibodies.
    Zupańska B; Brojer E; Maślanka K; Hallberg T
    Vox Sang; 1985; 49(1):67-76. PubMed ID: 4013144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
    Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
    Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Del red cells sensitized with anti-D are not phagocytosed by monocytes.
    Ogasawara K; Yabe R; Mazda T
    Transfusion; 1988; 28(6):603-4. PubMed ID: 3143172
    [No Abstract]   [Full Text] [Related]  

  • 25. Differences between the activities of human monoclonal IgG1 and IgG3 subclasses of anti-D(Rh) antibody in their ability to mediate red cell-binding to macrophages.
    Wiener E; Atwal A; Thompson KM; Melamed MD; Gorick B; Hughes-Jones NC
    Immunology; 1987 Nov; 62(3):401-4. PubMed ID: 3117677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantification of IgG anti-D bound to D-positive red cells infused into D-negative subjects after intramuscular injection of monoclonal anti-D.
    Kumpel BM; Judson PA
    Transfus Med; 1995 Jun; 5(2):105-12. PubMed ID: 7655572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity in the ability of IgG1 monoclonal anti-D to promote lymphocyte-mediated red cell lysis.
    Kumpel BM; Leader KA; Merry AH; Hadley AG; Poole GD; Blancher A; Goossens D; Hughes-Jones NC; Bradley BA
    Eur J Immunol; 1989 Dec; 19(12):2283-8. PubMed ID: 2481589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Murine monoclonal antibodies and human alloantisera specific for HLA inhibit monocyte phagocytosis of anti-D-sensitized human red blood cells.
    Neppert J; Marquard F; Mueller-Eckhardt C
    Eur J Immunol; 1985 Jun; 15(6):559-63. PubMed ID: 3924629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clearance of Rh D-positive red cells with monoclonal anti-D.
    Thomson A; Contreras M; Gorick B; Kumpel B; Chapman GE; Lane RS; Teesdale P; Hughes-Jones NC; Mollison PL
    Lancet; 1990 Nov; 336(8724):1147-50. PubMed ID: 1978026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-dependent cell-mediated cytotoxicity (ADCC) toward human O+ red cells coated with anti-D antibody: comparison between lymphocyte and monocyte ADCC activity.
    Sunada M; Suzuki S; Ota Z
    Acta Med Okayama; 1985 Apr; 39(2):77-89. PubMed ID: 3923782
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Functional study of 11 monoclonal anti-Rh D IgG antibodies. Attempt to define selection criteria with regard to their use in Rh immunoprophylaxis].
    Brossard Y; Gosset M; Feuillet-Fieux MN; Bignozzi C; Dangu C
    Rev Fr Transfus Immunohematol; 1988 Dec; 31(5):711-24. PubMed ID: 3148993
    [No Abstract]   [Full Text] [Related]  

  • 32. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
    Kumpel BM
    Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADCC (K-cell) lysis of human erythrocytes sensitized with rhesus alloantibodies. III. Comparison of IgG anti-D agglutinating and lytic (ADCC) activity and the role of IgG subclasses.
    Urbaniak SJ; Greiss MA
    Br J Haematol; 1980 Nov; 46(3):447-53. PubMed ID: 6778497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
    Kumpel BM
    Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ISBT monoclonal antibody workshop: report on group 3 (anti-Rh) antibodies.
    Lubenko A; Burslem SJ; Tandy J; Contreras M; Garner SF; Wiener E
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):145-52. PubMed ID: 3145543
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhanced uptake of anti-Rho coated red cells by cultured human monocytes.
    Ota H; Shimizu K
    Acta Haematol; 1974; 51(5):270-4. PubMed ID: 4209032
    [No Abstract]   [Full Text] [Related]  

  • 37. Anti-Rh workshop monoclonal antibodies.
    Bourel D; Gueguen-Duchesne M; Lecointre-Coatmelec M; Ferette J; Flageul S; Genetet N; Genetet B
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):157-66. PubMed ID: 3145545
    [No Abstract]   [Full Text] [Related]  

  • 38. Antibodies to human major histocompatibility complex products inhibit Fc gamma receptors types I and II.
    Neppert J; Jungi TW
    Transfus Med; 1996 Jun; 6(2):125-31. PubMed ID: 8809960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monocyte-mediated destruction in the presence of serum of red cells coated with antibody.
    Kurlander RJ; Rosse WF
    Blood; 1979 Nov; 54(5):1131-9. PubMed ID: 115513
    [No Abstract]   [Full Text] [Related]  

  • 40. ADCC activity of monoclonal anti-D antibodies.
    Urbaniak SJ; Stewart GM
    Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):237-43. PubMed ID: 3145551
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.